scholarly journals Direct-to-consumer mobile teledermoscopy for skin cancer screening: Preliminary results demonstrating willingness-to-pay in Australia

2018 ◽  
Vol 24 (10) ◽  
pp. 683-689 ◽  
Author(s):  
Centaine L Snoswell ◽  
Jennifer A Whitty ◽  
Liam J Caffery ◽  
Lois J Loescher ◽  
Nicole Gillespie ◽  
...  

Introduction Internationally, teledermoscopy has been found to have clinical and economic efficacy. This study aims to identify the attributes of a mobile teledermoscopy service that consumers prefer. This preliminary study was set within a broader randomised control trial (RCT) investigating the effectiveness of direct to consumer mobile teledermoscopy. Methods We undertook a discrete choice experiment (DCE). The DCE comprised 24 choice sets, divided into in two blocks of 12. For each choice set, respondents were asked to make discrete choices between two opt-out choices and two skin cancer screening service options described by seven attributes. A mixed logit model was used to estimate preferences for skin cancer screening services. Consumer preferences weights were used to calculate marginal willingness-to-pay (WTP) for skin cancer screening services. Results The DCE was completed by 113 consumer respondents. Consumers’ preference for dermatologist involvement in their diagnosis, increased accuracy, and reduced excisions were all statistically significant in driving choice between service models. Consumers preferred having a professional involved in their skin cancer screening, rather than performing a self-examination. Consumers were only WTP $1.18 to change from a GP visit to mobile teledermoscopy (diagnosis using a phone camera). However, they were WTP $43 to have their results reviewed by a dermatologist rather than a GP, and $117 to increase the chance of detecting a melanoma if it was present from 65-75% to 95%. Conclusion Skin cancer screening services which are delivered by health professionals, rather than skin self-examination, are preferred by consumers. Consumers were willing to pay for their preferred skin cancer screening method, especially if a dermatologist was involved.

2018 ◽  
Vol 21 ◽  
pp. S72 ◽  
Author(s):  
CL Snoswell ◽  
JA Whitty ◽  
LJ Caffery ◽  
L Loescher ◽  
N Gillespie ◽  
...  

2020 ◽  
Vol 85 ◽  
pp. 02003
Author(s):  
Marta Lange ◽  
Emilija Vija Plorina ◽  
Ilze Lihacova ◽  
Aleksandrs Derjabo ◽  
Janis Spigulis

Skin cancer is the most common type of cancers. In Latvia, on average there are approximately 200 new melanoma and 1300 non-melanoma cancer cases per year. Non-melanoma cancers are: Basal Cell Carcinoma, Squamous Cell Carcinoma and others. It is essential to discover skin cancer at an early stage when it is treatable. For this reason, a reliable, non-invasive and quantitative skin cancer screening method is necessary in order to discover skin cancer as early as possible and to help physicians such as general practitioners and dermatologists assign patients to the best treatment as soon as possible. In this article, the current skin cancer incidence as well as the screening situation in Latvia is described and a non-invasive skin screening method is proposed. The results show that this multispectral imaging method with a parameter p′ can distinguish melanoma from melanocytic nevi with sensitivity 75% and specificity 100%. Recommendations on distinguishing henangioma, seborrheic keratosis are described as well.


Sign in / Sign up

Export Citation Format

Share Document